Tablet formulations polymer coating

Enteric coating materials are also used to prevent release of the drug substance in the stomach if the drug is either an irritant to the gastric mucosa or unstable in gastric juice. Table 7 lists enteric coating polymers commonly used in tablet formulations. The choice of of enteric coating material depends on its solubility. 

TABLE 7 Enteric Coating Polymers Commonly Used in Tablet Formulations... 

Acetyltributyl citrate is used to plasticize polymers in formulated pharmaceutical coatings, including capsules, tablets, beads, and granules for taste masking, immediate release, sustained-release and enteric formulations. 

Polymethacrylates are primarily used in oral capsule and tablet formulations as film-coating agents.Depending on the type of polymer used, films of different solubility characteristics can be produced see Table II. 

Sugar spheres are mainly used as inert cores in capsule and tablet formulations, particularly multiparticulate sustained-release formulations. They form the base upon which a drug is coated, usually followed by a release-modifying polymer coating. 

The stereoselective release behaviors of low-swelling molecularly imprinted polymer bead matrices in pressed-coat tablets were studied using either R- or S-propranolol selective MIPs. The in vitro release profiles of the low-swelling matrices showed a difference in the release of enantiomers, in that the nontemplate isomer was released faster than the template isomer. However, in the last phase of dissolution this difference was reduced and later reversed [64]. Stereoselectivity of release profiles for propranolol enantiomers were identified in MIP synthetic membranes from tablet formulations with significant differences between enantiomers [65]. Release of the enantiomer used as the print was always faster than the... 

Adhesion between the polymeric film and substrate is a major concern. Poor adhesion could result in flaking or peeling of the coating from the substrate core. Moisture could accmnulate at the film-substrate interface and compromise the mechanical protection provided by the coating. Polymer adhesion is related to both film-substrate interfacial interactions and internal stresses within the film. Polymer adhesion can be evaluated by peel tests or butt joint tests. Apart from the specific properties of the polymers, excipients used in tablet formulations can influence film-tablet adhesion. Since adhesion between a polymer and the tablet smface is due primarily to hydrogen bond formation, hydrophobic agents may decrease adhesion by... 

Some tablets combine sustained-release and rapid disintegration characteristics. Products such as K-Dur (Key Pharmaceuticals) combine coated potassium chloride crystals in a rapidly releasing tablet. In this particular instance, the crystals are coated with ethylcellulose, a water-insoluble polymer, and are then incorporated into a rapidly disintegrating microcrystalline cellulose (MCC) matrix. The purpose of this tablet is to minimize GI ulceration, commonly encountered by patients treated with potassium chloride. This simple but elegant formulation is an example of a solid dosage form strategy used to achieve clinical goals. 

Duloxetine hydrochloride, a novel anti-depressive, is known to be acid labile and, consequently, it has been formulated as an enteric-coated tablet. Interestingly, Jansen et al. [97] subsequently found that the drug was destabilised by degradation products within these enteric polymers. The authors found that succinyl and phthalyl residues from the hydroxypropyl methylcellulose acetate succinate (HPMCAS) and hydroxypropyl methylcellulose phthalate (HPMCP) formed... 

A number of patented technologies for multiparticulate dosage forms have been described recently, such as the Micropump system, which is an osmotically driven coated microparticle system designed to increase the absorption time for rapidly absorbed drugs.59 Combination of water-soluble and water-insoluble polymers could provide enhanced controlled release rates and profiles. A patented technology (COSRx) has been reported to be capable of delivering various sophisticated release profiles. The formulation involves a guar-gum-based tablet and a combination of water-soluble and water-insoluble polymeric tablet coat.60... 

---